Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer's disease.
Munafò A, Cantone AF, Di Benedetto G, Torrisi SA, Burgaletto C, Bellanca CM, Gaudio G, Broggi G, Caltabiano R, Leggio GM, Bernardini R, Cantarella G. Munafò A, et al. Among authors: burgaletto c. Front Pharmacol. 2024 Mar 26;15:1386224. doi: 10.3389/fphar.2024.1386224. eCollection 2024. Front Pharmacol. 2024. PMID: 38595916 Free PMC article.
TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β.
Di Benedetto G, Burgaletto C, Serapide MF, Caltabiano R, Munafò A, Bellanca CM, Di Mauro R, Bernardini R, Cantarella G. Di Benedetto G, et al. Among authors: burgaletto c. Int J Mol Sci. 2022 Oct 1;23(19):11625. doi: 10.3390/ijms231911625. Int J Mol Sci. 2022. PMID: 36232931 Free PMC article.
Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease.
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Musumeci T, et al. Among authors: burgaletto c. Biomedicines. 2022 Apr 23;10(5):985. doi: 10.3390/biomedicines10050985. Biomedicines. 2022. PMID: 35625722 Free PMC article.
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.
Palmas MF, Ena A, Burgaletto C, Casu MA, Cantarella G, Carboni E, Etzi M, De Simone A, Fusco G, Cardia MC, Lai F, Picci L, Tweedie D, Scerba MT, Coroneo V, Bernardini R, Greig NH, Pisanu A, Carta AR. Palmas MF, et al. Among authors: burgaletto c. Neurotherapeutics. 2022 Jan;19(1):305-324. doi: 10.1007/s13311-022-01182-2. Epub 2022 Jan 24. Neurotherapeutics. 2022. PMID: 35072912 Free PMC article.
Alzheimer's disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis.
Dvir-Szternfeld R, Castellani G, Arad M, Cahalon L, Colaiuta SP, Keren-Shaul H, Croese T, Burgaletto C, Baruch K, Ulland T, Colonna M, Weiner A, Amit I, Schwartz M. Dvir-Szternfeld R, et al. Among authors: burgaletto c. Nat Aging. 2022 Jan;2(1):60-73. doi: 10.1038/s43587-021-00149-w. Epub 2021 Dec 20. Nat Aging. 2022. PMID: 37118355
17 results